相关实验视频
Updated: Jan 31, 2026

16:11
Implementation of a Reference Interferometer for Nanodetection
Published on: April 26, 2014
9.8K
药剂师协作实践协议对老年医学转诊患者的药物基因组实施的影响
Rachel C Larmer1, Gina Elder2, Alayna M Wagner1
1Department of Pharmacy, Cleveland Clinic, Cleveland, OH.
Journal of the American Pharmacists Association : JAPhA
|January 29, 2026
概括
实施药剂师协作实践协议 (CPA) 简化了老年病学中的药物基因组 (PGx) 服务. 这减少了PGx测试的等待时间,并导致了潜在不合适药物 (PIMs) 的显著停用.
科学领域:
- 药物基因组学 药物基因组学
- 老年医学 老年医学
- 临床药房 临床药房
背景情况:
- 以前,老年诊所的患者需要与药物学 (PGx) 药剂师和临床遗传学家进行双重咨询.
- 这种多步骤的过程造成了延迟和患者退出.
- 制药师协作实践协议 (CPA) 被引入以简化PGx服务.
研究的目的:
- 评估CPA对老年诊所内PGx服务的影响.
- 为了比较从转诊到初次PGx药剂师访问的时间,在CPA实施之前和之后.
- 评估药物管理和测试完成率的变化.
主要方法:
- 追溯队列研究,涉及60岁及以上的成年人,转诊进行PGx测试.
- 对比CPA前 (2019年5月-2021年10月) 和CPA后 (2022年1月-2023年5月) 的转诊和访问时间表.
- 对测试完成率,可操作结果和药物干预措施的分析.
主要成果:
- 在CPA实施后,从转诊到初次访问的时间减少了39%.
- 超过30%的潜在不合适药物 (PIMs) 在六个月内停止使用.
- 保持了成功完成PGx测试和可操作结果的高率.
结论:
- 实施CPA对药剂师领导的PGx测试服务产生了积极的影响.
- 在老年人群中,CPA促进了更有效的患者护理和药物优化.
- 简化工作流程可以提高老年医疗机构的个性化医疗服务.
相关概念视频
Drug Dosing: Geriatric Patients
269
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
269
Pharmacodynamics in Geriatric Patients: Effects of Age
235
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
235
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
259
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
259
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
215
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
215
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
253
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
253
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
701
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
701

